Revance Therapeutics Inc (NASDAQ:RVNC)

Delayed Data
As of Jan 21
 -0.60 / -4.28%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Revance Therapeutics Inc have a median target of 26.50, with a high estimate of 55.00 and a low estimate of 17.00. The median estimate represents a +97.32% increase from the last price of 13.43.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Revance Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -0.89%
Growthannually 16.84%


Growthquarterly 20.59%
Growthannually 393.34%
Key to the earnings and sales forecast charts.